FDA staff recommends stronger label for 2 eczema drugs - Related Stories - AAP SmartBrief
Links shared publicly online about this topic.
FDA staff said eczema medicines Elidel from Novartis and Protopic from Astellas Pharma might need to carry a warning label that mentions cases of cancer and infection in children. The staff reported the information ahead of a panel review on the safety of drugs used by children. <a href='/servlet/aa View full resource at smartbrief.com
Most Recently Shared on March 20, 2010 at 1:00 am By: